Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants

por Gorelik, Maryna, Sidhu, Sachdev S.
Publicado 2016

A T cell redirection platform for co-targeting dual antigens on solid tumors

por Enderle, Leonie, Shalaby, Karim H., Gorelik, Maryna, Weiss, Alexander, Blazer, Levi L., Paduch, Marcin, Cardarelli, Lia, Kossiakoff, Anthony, Adams, Jarrett J., Sidhu, Sachdev S.
Publicado 2021

A Quantitative Assay for Ca(2+) Uptake through Normal and Pathological Hemichannels

por Nardin, Chiara, Tettey-Matey, Abraham, Donati, Viola, Marazziti, Daniela, Di Pietro, Chiara, Peres, Chiara, Raspa, Marcello, Zonta, Francesco, Yang, Guang, Gorelik, Maryna, Singh, Serena, Cardarelli, Lia, Sidhu, Sachdev S., Mammano, Fabio
Publicado 2022

Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins

por Mishra, Nawneet, Teyra, Joan, Boytz, RuthMabel, Miersch, Shane, Merritt, Trudy N., Cardarelli, Lia, Gorelik, Maryna, Mihalic, Filip, Jemth, Per, Davey, Robert A., Sidhu, Sachdev S., Leung, Daisy W., Amarasinghe, Gaya K.
Publicado 2022

Monoclonal antibodies binding data for SARS-CoV-2 proteins

por Mishra, Nawneet, Teyra, Joan, Boytz, RuthMabel, Miersch, Shane, Merritt, Trudy N., Cardarelli, Lia, Gorelik, Maryna, Mihalic, Filip, Jemth, Per, Davey, Robert A., Sidhu, Sachdev S., Leung, Daisy W., Amarasinghe, Gaya K.
Publicado 2022

Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations

por Miersch, Shane, Li, Zhijie, Saberianfar, Reza, Ustav, Mart, Brett Case, James, Blazer, Levi, Chen, Chao, Ye, Wei, Pavlenco, Alevtina, Gorelik, Maryna, Garcia Perez, Julia, Subramania, Suryasree, Singh, Serena, Ploder, Lynda, Ganaie, Safder, Chen, Rita E., Leung, Daisy W., Pandolfi, Pier Paolo, Novelli, Giuseppe, Matusali, Giulia, Colavita, Francesca, Capobianchi, Maria R., Jain, Suresh, Gupta, J.B., Amarasinghe, Gaya K., Diamond, Michael S., Rini, James, Sidhu, Sachdev S.
Publicado 2021

Structural surfaceomics reveals an AML-specific conformation of integrin β(2) as a CAR T cellular therapy target

por Mandal, Kamal, Wicaksono, Gianina, Yu, Clinton, Adams, Jarrett J., Hoopmann, Michael R., Temple, William C., Izgutdina, Adila, Escobar, Bonell Patiño, Gorelik, Maryna, Ihling, Christian H., Nix, Matthew A., Naik, Akul, Xie, William H., Hübner, Juwita, Rollins, Lisa A., Reid, Sandy M., Ramos, Emilio, Kasap, Corynn, Steri, Veronica, Serrano, Juan Antonio Camara, Salangsang, Fernando, Phojanakong, Paul, McMillan, Melanie, Gavallos, Victor, Leavitt, Andrew D., Logan, Aaron C., Rooney, Cliona M., Eyquem, Justin, Sinz, Andrea, Huang, Benjamin J., Stieglitz, Elliot, Smith, Catherine C., Moritz, Robert L., Sidhu, Sachdev S., Huang, Lan, Wiita, Arun P.
Publicado 2023